DOYLE JOHN BRENDAN (Chief Financial Officer) reported 1 transaction at COGNITION THERAPEUTICS INC
Review the transaction codes below to understand the nature of each event.
Filed: 2/18/2026ACC: 0001104659-26-017068
Officer· Chief Financial Officer
Since Feb 2026
-1.56K
Net shares
Net seller
$1.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.56K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.56K
Price / share
$1.12
Trade value
$1.75K
% of position
0.3%
2/15/2026
619.07K→617.51K
Total
Net shares
−1.56K
Net value
-$1.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2026 | F · Tax Withholding | −1.56K | $1.12 | $1.75K | 0.3% | 619.07K | 617.51K |
| Total | −1.56K | -$1.75K | ||||||
Derivative Transactions0
No derivative transactions reported